# Neuland Laboratories Limited (Unit I) - Inspection Records

Source: https://www.keypedia.com/companies/neuland-laboratories-limited-unit-i/2ab72f34-8d5a-4919-8777-83a4fa3cadd5

> Inspection records and compliance data for Neuland Laboratories Limited (Unit I) in Bonthapalle, None. Access full analysis and detailed observations.

---

## Details

- Name: Neuland Laboratories Limited (Unit I)
- FEI Number: 3003289270
- City: Bonthapalle
- State: None
- Country Name: India
- Address Line 1: Veerabhadraswamy Temple Road, 473 474 490/2 Survey No 347
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1235885 - Neuland Laboratories Limited (Unit I) - 2024-03-22](https://www.keypedia.com/records/fda_inspections/neuland-laboratories-limited-unit-i/f94781ca-7390-4a22-9503-a0ac1b906e8d) — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2024
- [483 - Neuland Laboratories Limited (Unit I) - 2019-06-21](https://www.keypedia.com/records/483/neuland-laboratories-limited-unit-i/aa82ff67-fa6e-4140-a7f8-35b538357150) — source: FDA, date: June 21, 2019
- [FDA Inspection 1096367 - Neuland Laboratories Limited (Unit I) - 2019-06-21](https://www.keypedia.com/records/fda_inspections/neuland-laboratories-limited-unit-i/890e508f-3d21-413b-ba63-8a03b7badcad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2019
- [FDA Inspection 1010033 - Neuland Laboratories Limited (Unit I) - 2017-04-07](https://www.keypedia.com/records/fda_inspections/neuland-laboratories-limited-unit-i/5cbf351d-bb9c-4c1e-8580-92ab05fb1f90) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 7, 2017
- [FDA Inspection 891418 - Neuland Laboratories Limited (Unit I) - 2014-04-25](https://www.keypedia.com/records/fda_inspections/neuland-laboratories-limited-unit-i/5f8c722a-6e7d-40d9-aacf-ef58a6d3562d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 25, 2014
- [FDA Inspection 700774 - Neuland Laboratories Limited (Unit I) - 2010-11-25](https://www.keypedia.com/records/fda_inspections/neuland-laboratories-limited-unit-i/ed7959d2-2e26-4b05-b689-cd3e78fc02e0) — classification: No Action Indicated (NAI), source: FDA, date: November 25, 2010

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Astellas Pharma Inc.](https://www.keypedia.com/companies/astellas-pharma-inc/23dd5b22-f65a-44d8-ba32-8de91558f67f)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/fc196e7f-0f5e-4ef1-afa6-3023ca6df1f3)
- [FUJIFILM Diosynth Biotechnologies UK Limited](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-uk-limited/1ab271fe-bbf2-4dec-a2b8-1ae59ca0f082)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)
- [Roche Singapore Technical Operations Pte. Ltd.](https://www.keypedia.com/companies/roche-singapore-technical-operations-pte-ltd/e32730ce-85e1-4b01-8f9b-a8215d0593ca)
- [Aptuit (Oxford) Ltd.](https://www.keypedia.com/companies/aptuit-oxford-ltd/da0ef59c-f35f-478c-a844-0d223aa34b67)

## Related Officers

- [investigator](https://www.keypedia.com/people/nije-a-thomas/3d1ede3c-d04e-4c2e-a9a8-61261f4d44b5)
- [Jennifer L. Huntington](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)